Obexelimab almost completely prevented new inflammatory lesions visible on brain scans of adults with relapsing MS, per trial data.

Learn about multiple sclerosis, its symptoms, causes, and treatment options. Understand how early diagnosis helps in managing ...

Panelists discuss how schizophrenia imposes significant economic costs across direct medical expenses, nonmedical expenses, and indirect costs, with negative symptoms particularly amplifying the ...

BRIUMVI is currently approved in the United States, as well as several countries outside of the U.S., as a one-hour intravenous (IV) infusion administered twice a year, following the starting dose, in ...

Discover how CAR T cell therapy is breaking new ground in treating Multiple Sclerosis for the first time in the UK ...

Scientists have found blood protein signals that may flag multiple sclerosis up to seven years before symptoms begin.

Many people with MS are heat sensitive, so keeping cool can help. There are cooling vests and other types of clothing available, and cold drinks, hydration, shady locations, and a hat can help.

A major UK-wide study led by researchers based in Liverpool has revealed the profound impact of multiple sclerosis (MS) on ...

Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...

Obexelimab met primary endpoint with a 95% relative reduction in new gadolinium (Gd)-enhancing T1 lesions compared with placebo, p=0.0009 ...

Peripheral neuropathy can be a symptom of chronic Lyme disease, causing burning, tingling, and numbness in extremities ...

A biology teacher has become the first patient in the UK to receive “gamechanger” therapy to treat multiple sclerosis.